The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients
- 11 August 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Electrocardiology
- Vol. 62, 59-64
- https://doi.org/10.1016/j.jelectrocard.2020.08.008
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactionsBMJ Open, 2013
- Azithromycin and the Risk of Cardiovascular DeathThe New England Journal of Medicine, 2012
- Azithromycin‐Induced Torsade De PointesPacing and Clinical Electrophysiology, 2007
- Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointesAmerican Heart Journal, 2007
- Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factorsJournal of Interventional Cardiac Electrophysiology, 2007
- Antimicrobial-Associated QT Interval Prolongation: Pointes of InterestClinical Infectious Diseases, 2006
- Anti-HERG activity and the risk of drug-induced arrhythmias and sudden deathEuropean Heart Journal, 2005
- Divergent Proarrhythmic Potential of Macrolide Antibiotics Despite Similar QT Prolongation: Fast Phase 3 Repolarization Prevents Early Afterdepolarizations and Torsade de PointesThe Journal of pharmacology and experimental therapeutics, 2002
- Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudineClinical Therapeutics, 1996
- The pharmacokinetics of azithromycin and their clinical significanceEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991